The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995; 333:1581–7.
2.
WahlgrenNAhmedNDavalosA. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet2007; 369:275–82.
3.
HackeWKasteMBluhmkiE. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med2008; 359:1317–29.
4.
SandercockPLindleyRWardlawJ. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials2008; 9:37.
5.
WhiteleyWLindleyRWardlawJSandercockP. Third international stroke trial. Int J Stroke2006; 1:172–6.
6.
KobayashiASkowronskaMLitwinTCzlonkowskaA. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated. Emerg Med J2007; 24:96–9.
